Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2006Molecular Cancer TherapeuticsOpen Access

Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function

View Full Paper
Ask AI
Bookmark
Share

Authors

CRCécile RouleauFidelity Biosciences (United States)ARAndré RoyCentre Hospitalier Avranches GranvilleTMThia St MartinBedford Research Foundation

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rouleau et al. (2006) studied this question.

synapsesocial.com/papers/6a749c1099129e9915f54889https://doi.org/10.1158/1535-7163.mct-05-0289
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immunohistology of the Antigenic Pattern of a Continuous Cell Line From a Human Colon Tumor1975 · 146 citations
  2. 2Catalytic domain of PRL-3 plays an essential role in tumor metastasis: Formation of PRL-3 tumors inside the blood vessels2004 · 95 citations
  3. 3Determination of Cell Surface Membrane Antigens Common to Both Human Neuroblastoma and Leukemia-Lymphoma Cell Lines by a Panel of 38 Monoclonal Antibodies 21984 · 79 citations